Last:
Change: Change(%):
Volume: Open:
High: Low:
52Wk High: 52Wk Low:

Enanta's research and development efforts are currently focused on the following disease targets: respiratory syncytial virus (RSV), non-alcoholic steatohepatitis (NASH)/ primary biliary cholangitis (PBC), and hepatitis B virus (HBV).